To gain insights into coordinated lineage-specification and morphogenetic processes during early embryogenesis, here we report a systematic identification of transcriptional programs mediated by a key developmental regulator-Brachyury. High-resolution chromosomal localization mapping of Brachyury by ChIP sequencing and ChIP-exonuclease revealed distinct sequence signatures enriched in Brachyury-bound enhancers. A combination of genomewide in vitro and in vivo perturbation analysis and cross-species evolutionary comparison unveiled a detailed Brachyury-dependent gene-regulatory network that directly links the function of Brachyury to diverse developmental pathways and cellular housekeeping programs. We also show that Brachyury functions primarily as a transcriptional activator genome-wide and that an unexpected gene-regulatory feedback loop consisting of Brachyury, Foxa2, and Sox17 directs proper stem-cell lineage commitment during streak formation. Target gene and mRNA-sequencing correlation analysis of the T c mouse model supports a crucial role of Brachyury in up-regulating multiple key hematopoietic and musclefate regulators. Our results thus chart a comprehensive map of the Brachyury-mediated gene-regulatory network and how it influences in vivo developmental homeostasis and coordination.
To gain insights into coordinated lineage-specification and morphogenetic processes during early embryogenesis, here we report a systematic identification of transcriptional programs mediated by a key developmental regulator-Brachyury. High-resolution chromosomal localization mapping of Brachyury by ChIP sequencing and ChIP-exonuclease revealed distinct sequence signatures enriched in Brachyury-bound enhancers. A combination of genomewide in vitro and in vivo perturbation analysis and cross-species evolutionary comparison unveiled a detailed Brachyury-dependent gene-regulatory network that directly links the function of Brachyury to diverse developmental pathways and cellular housekeeping programs. We also show that Brachyury functions primarily as a transcriptional activator genome-wide and that an unexpected gene-regulatory feedback loop consisting of Brachyury, Foxa2, and Sox17 directs proper stem-cell lineage commitment during streak formation. Target gene and mRNA-sequencing correlation analysis of the T c mouse model supports a crucial role of Brachyury in up-regulating multiple key hematopoietic and musclefate regulators. Our results thus chart a comprehensive map of the Brachyury-mediated gene-regulatory network and how it influences in vivo developmental homeostasis and coordination.
primitive streak | early development | mesoendoderm differentiation I n the past decade, significant insights have been gained in understanding gene-regulatory programs responsible for embryonic stem (ES) cell pluripotency and self-renewal. However, transcriptional control mechanisms underlying finely balanced lineage-segregation and morphogenetic processes during early mammalian embryogenesis remained elusive. During early mouse gastrulation, Brachyury (T), a classical enhancer-binding transcription factor (TF), has been reported to be required for the proper development of primitive streak, allantois, axial, and posterior mesoderm (reviewed in ref. 1) .
Specifically, mouse embryos that are homozygous for the Brachyury (T) deletion die at midgestation (2) . T −/− mutant epiblast cells are compromised in their ability to migrate away from the primitive streak and, therefore, are unable to undergo the morphogenetic movements carried out by their wild-type (WT) counterparts during gastrulation. In addition to defects in the primitive streak, the notochord is absent in posterior portions of the embryo. Although the anterior portions of T mutant mice contain notochordal precursor-like cells, they fail to undergo normal terminal differentiation (3, 4) . The embryonic pattern posterior to the forelimb region of T −/− animals is also disturbed, with somites posterior to the seventh pair absent or abnormal. Although neural folds fuse to form the neural tube, they are severely kinked in the caudal region, and the surface ectoderm tends to form fluid-filled blisters (2, 4, 5) . In addition to these well-documented defects, numerous other phenotypic abnormalities have been reported in T −/− and T mutant embryos, including left-right patterning defects and morphological abnormalities in heart development (6, 7) . Together, these genetic and phenotypic analyses strongly suggest that Brachyury and Brachyury-expressing cells play diverse and indispensable roles in early mouse development.
In mouse ES cell-based differentiation systems, Brachyury is widely used as a mesoendoderm marker, and Brachyury-positive cells were able to differentiate into mesodermal and definitive endodermal lineages, such as cardiomyocytes and hepatocytes (8) (9) (10) . In a previous study, we found that depletion of a core promoter factor, the TATA binding protein-associated factor 3, in ES cells leads to significant up-regulation of Brachyury and mesoderm lineages during ES cell differentiation (11) . Here, we systematically characterized the molecular function of Brachyury during ES cell differentiation by genomic, single-cell imaging, and biochemical approaches. We then contrasted our results with published zebrafish and Xenopus Brachyury binding site mapping data (12, 13) to compare evolutionarily convergent or divergent pathways. We further extended these studies to examine the direct impact of Brachyury loss of function during early development with the Tc mouse model. Together, our data provide a systematic and comprehensive view of Brachyury-mediated regulation and also reveal unique mechanistic insights into how this gene network likely contributes to early mouse embryogenesis.
Results and Discussion
Characterization of in Vitro Primitive Streak Induction. We used the well-established Activin-A-mediated differentiation protocol that efficiently drives ES cells to form primitive streak cells in vitro (9, 14) (SI Appendix, Fig. S1A ). We successfully generated two highly specific polyclonal antibodies directed against the Brachyury protein. At day 4 after differentiation, we detected strong induction of primitive streak markers (Brachyury and Gsc) (SI Appendix, Figs. S1 B-D and S2A), indicating a successful differentiation of primitive streak cells. To comprehensively
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This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. 1073/pnas.1402612111/-/DCSupplemental. characterize gene expression changes upon differentiation, we performed mRNA sequencing (mRNA-seq) with differentiated embryoid bodies (EBs; EB day 4) and then compared gene expression levels to ES cell data. We detected 2,464 up-regulated and 1,329 down-regulated genes (statistics in Dataset S1). Consistent with a successful epiblast transition and primitive streak induction, ES cell ground-state specific genes (Tbx3, Stra8, Pecam1, Esrrb, Gbx2, and Klf4) were dramatically down-regulated. However, mesoderm and definitive endoderm (DE) markers (Cer1, Eomes, Wnt3, Lhx1, Fgf8, Cxcr4, Foxa2, Sox17, and Gsc) (15) were strongly up-regulated (SI Appendix, Figs. S1C and S2B). We also confirmed the expression of Brachyury, Foxa2, and Sox17 at the protein level by immunofluorescence staining (SI Appendix, Fig. S1D ).
Brachyury Selectively Binds Key Developmental Genes. We applied ChIP sequencing (ChIP-seq) to our in vitro primitive streak formation system. To ensure specific detection of Brachyury binding, we used two independent anti-Brachyury antibodies for ChIP-seq experiments. By only calling peaks detected by both antibodies, we identified 3,160 high-confidence Brachyury-bound regions in the mouse genome (Dataset S2). These sites display genome-wide biased association with transcription start sites (TSS; 61% are within 5 kb of a TSS vs. 9% of random control regions) ( Fig. 1 A and B) . Intriguingly, we also observed a strong biased localization of Brachyury bound at regions immediate downstream of the TSS, particularly the 5′ UTR ( Fig. 1C and SI Appendix, Fig. S1 E and F). As expected, many key developmental genes (Fgf8, Foxa2, Foxj1, Sox17, and Dusp6) were directly targeted by Brachyury (Fig. 1A and SI Appendix, Fig. S8 ). We correlated Brachyury-binding site information with annotated genes genome-wide (<10 kb from TSS) and identified 1,942 genes bound by Brachyury (Dataset S3). To calculate overrepresented Gene Ontology terms associated with Brachyury binding, we next performed Genomic Regions Enrichment of Annotations Tool (GREAT) analysis (16) (Fig. 1D) . We found that Brachyurybound regions were significantly enriched around genes involved in the formation of primary germ layers (P < 1.4E-9), mesoderm cell migration (P < 3.0E-7), and mesoderm formation (P < 1.2E-5). Recently, Brachyury was found to express in DE progenitors, and Brachyury-positive cells were able to efficiently differentiate into definitive endodermal cell types in vitro and in vivo (8, 9) .
In line with these findings, Brachyury-bound regions were also enriched around genes involved in endoderm development (P < 3.9E-09) and formation (P < 2.6E-05).
Evolutionary Conservation of Brachyury-Mediated Regulation. With recent Brachyury homolog Ntl ChIP-on-chip (zebrafish) and XBra ChIP-seq (Xenopus tropicalis) data available (12, 13), we next asked whether a similar set of target genes identified in these studies also bound Brachyury in the mouse. Intriguingly, we found that ∼10∼13% of the Ntl (zebrafish) and Xbra (X.tropicalis) target genes (zebrafish, 28/218; X. tropicalis, 113/1,040) have a corresponding homologous gene bound by Brachyury in mouse ( Fig. 1E and Dataset S3). For example, nine genes (Dusp6, Mesp2, Hoxd8, Cdx2, Irx3, Lefty1, Msgn1, Dhrs3, and Sp5) were bound by Brachyury in all three species (Fig. 1F) . We also observed Brachyury-bound genes such as Fgf8, Sox17, Foxa2, Tbx3, Wnt9b, Wnt5b, and Rest that were common targets in mouse and X. tropicalis but not in zebrafish ( Fig. 1F and Dataset S3). Conversely, Igf1r, Brf1, Gata2, Zfand5, Sox11, Mycn, Notch3, etc. are common targets in mouse and zebrafish but not in X. tropicalis. It is worth noting that the work performed in zebrafish used the promoter-restricted ChIP-on-chip technique (12 kb around the TSS of ∼11,000 genes) to map what is likely to be a relatively incomplete set of Brachyury-binding sites. We would therefore expect to observe larger function overlaps between mouse and zebrafish targets when more sensitive binding-site mapping techniques were used.
Map High-Resolution Brachyury-Binding Sites by ChIP-Exonuclease.
Previous in vitro studies suggested that Brachyury selectively binds a 7-bp DNA motif (TCACACCT) (17) (18) (19) . However, surprisingly, this motif was not evident from Brachyury ChIP-on-chip data in a recent report (20) and in our ChIP-seq datasets. To resolve this discrepancy, we applied the much-higher-resolution ChIP-exonuclease (ChIP-exo) technique to our in vitro primitive streak formation system. Exonuclease treatment steps in the ChIPexo protocol remove extraneous flanking DNA from the crosslinked protein-DNA complexes (21) , allowing a more precise delineation of DNA sequences recognized and bound by Brachyury (SI Appendix, Fig. S3A ). Indeed, after peak calling by GeneTrack (22), we were able to detect 11,503 bifurcated ChIP-exo peaks [11,000 (11k) dataset]. The average size of the binding sites was ∼11 base pairs (bp), compared with 823 bp for a typical ChIP-seq binding region. This significant improvement in resolution (∼76-fold) provided us with a more accurate view of Brachyuryenhancer DNA interactions (SI Appendix, Fig. S3B ). ChIP-exo allowed us to successfully identify an overrepresented DNA motif (TCACA) (1k dataset, top 10% of 11k dataset) that matched well with the Brachyury consensus sequence (P < 2.22E-16) (SI Appendix, Fig. S3 C and D) . Genome-wide scanning (11k dataset) further confirmed that 37% of the Brachyury exo-peaks (4,299 of 11,503) contain this motif (Fig. 2D) . As expected, DNA probes containing these 5 bp were sufficient to interact specifically with Brachyury in EMSAs (SI Appendix, Fig. S4 A and B) . Supershift assays confirmed that this binding is Brachyury-specific (SI Appendix, Fig. S4C ). Strikingly, we observed that there are frequently multiple Brachyury-binding sites within each ChIP-seqdefined enhancer region. For example, Foxa2, Cer1, and Wnt8b proximal enhancers (PEs) contain as many as eight Brachyury exo-peaks (SI Appendix, Fig. S3E ). On average, there are ∼2.4 Brachyury-binding sites within each ChIP-seq region ( Fig. 2A) .
Unique Sequence Signatures in Brachyury-Bound Enhancers. An important finding of the ENCODE (Encyclopedia of DNA Elements) project was that many eukaryotic genes are regulated by multiple TFs cobinding to neighboring sites in the genome (23) . To test whether this characteristic is also the case for Brachyurybound enhancers, we performed a motif search within 50 bp around Brachyury ChIP-exo peaks (1k dataset). We recovered five overrepresented motifs (Fig. 2B and SI Appendix, Fig. S5A ). Importantly, four of the five identified motifs were confidently matched to known TF binding sequences (Brachyury, Myf family, E2F1, and Sox17) (Fig. 2C ). In agreement with bona fide TF binding events, a positional preference plot confirmed the enrichment for these motifs only at Brachyury exo-peaks but not within their flanking extended genomic regions (±200 bp) (Fig.  2E) . Consistent with the notion of combinatorial regulation, we observed extensive double-and triple-motif colocalization (11k dataset) (Fig. 2D and SI Appendix, Fig. S5B) , and the frequencies of colocalization were significantly higher (up to sixfold) than values calculated for random control genomic regions (Fig. 2D) . These sequence signatures identified here provided us with valuable information to further dissect complex molecular transactions at Brachyury-bound enhancers. Fig. S6A ). Compared with nontarget shRNA control, we detected 567 downregulated and 806 up-regulated genes common to the two distinct Brachyury shRNA-mediated knockdowns. Next, we set out to test whether there is a biased association of Brachyury sites with particular gene categories (up, down, and unchanged) upon Brachyury depletion. To do so, we first assigned Brachyury-bound regions that were within 5 kb of the TSS to genes genome-wide. Then, we analyzed the association between Brachyury-bound regions with each gene category (SI Appendix, Fig. S6B ). Notably, we only detected a biased association of Brachyury sites with genes that were down-regulated upon loss of Brachyury, whereas the opposite correlation was seen for up-regulated genes. This genome-wide biased association strongly favors the notion that, upon induction, Brachyury binds to the promoter and enhancer regions of target genes and activates transcription. Consistent with this model, representative Brachyury-bound regions and, likewise, a synthetic DNA element containing four repeats of the Brachyury DNA-binding motif efficiently elevated the gene expression of a firefly luciferase reporter in a Brachyury-dependent manner in human 293T cells (SI Appendix, Figs. S6C and S7).
Brachyury Functions as an
Activator. To probe how Brachyury regulates its target genes, we performed mRNA-seq to analyze gene-expression changes after Brachyury depletion by two independent lentivirus-mediated shRNAs (SI Appendix,
Brachyury Coordinates Gene Expression During in Vitro Streak
Formation. To dissect how Brachyury regulates gene expression at the single-cell level, we focused on two Brachyury direct target genes, Foxa2 and Sox17 (Fig. 1A and SI Appendix, Fig. S8B) . Interestingly, the target gene analysis comparing divergent species indicated that both Foxa2 and Sox17 were also targeted by the Brachyury homolog (XBra), suggesting that the regulatory link between Brachyury, Foxa2, and Sox17 might be evolutionarily conserved ( Fig. 1 E and F) . Furthermore, Brachyury depletion decreased Foxa2 and Sox17 expression at both protein and mRNA levels ( Fig. 3A and SI Appendix, Fig. S9 A and B) . After double or triple immunofluorescence staining, we performed single-cell analysis to test the correlation of expression between genes (Fig. 3B and SI Appendix, Fig. S9 C and D) . Collectively, our single-cell imaging analysis revealed several important correlations regarding the relationship between Brachyury, Foxa2, and Sox17 (Fig. 3B  and SI Appendix, Fig. S9C ). Firstly, Foxa2 high and Sox17 high cells were mutually exclusive, as highlighted by the negative correlation between their expression levels. We also identified a negative correlation between Sox17 and Brachyury. In contrast, the expression of Foxa2 was always positively correlated with Brachyury expression (Fig. 3B) . We also observed a population of cells with high levels of Brachyury and medium-to-low levels of Sox17 and Foxa2 (SI Appendix, Fig. S9D ), suggesting coexpression of Brachyury, Foxa2, and Sox17 within the same individual cells.
Together with genomic data, our single-cell imaging results favor a model in which, as differentiation occurs, Brachyury first targets and promotes the expression of Foxa2 and Sox17. However, high levels of Sox17 would, in turn, directly or indirectly repress the expression of Brachyury (Fig. 3H) . This potential negative feedback may explain the Sox17 high Brachyury low Foxa2 low cell population. To directly test this model, we overexpressed Sox17 after 2 days of differentiation when cells are at the epiblast stage. Indeed, we observed significant down-regulation of Brachyury at EB day 4 (Fig. 3C ).
To further test this model in vivo, we first asked whether Brachyury, Sox17, and Foxa2 also displayed gene-expression patterns that spatially overlap during early mouse development. We first compared publicly available in situ hybridization (ISH) gene expression data (24) . Indeed, we detected coexpression of Brachyury and Foxa2 at node/DE regions and coexpression of Foxa2 and Sox17 at DE regions (SI Appendix, Fig. S9E ). Consistent with our in vitro results, we found that Brachyury and Sox17 expression was negatively correlated in the definite endoderm region. If the model derived from our in vitro experiments is correct, we would expect to detect a Brachyury medium Sox17 medium cell population, suggesting an intermediate transition state wherein Brachyury first activates the expression of Sox17 and increasing levels of Sox17 gradually represses the expression of Brachyury. To further probe the coregulated gene expression at the single-cell level, we performed confocal imaging experiments of coimmunostained 7.0∼7.5 mouse embryos (Fig. 3 D and E, SI Appendix, Fig. S10 , and Movies S1-S4). As expected, we detected a Brachyury medium Sox17 medium cell population in the DE region, but not at other regions, in embryonic day 7.5 (E7.5) embryos (Fig. 3 D and F, SI Appendix, Fig. S10A , and Movie S1). Interestingly, Brachyury medium Sox17 medium cells are generally found located more distal to the midline of the notochord-primitive streak compared with Brachyury high Sox17 low cells, suggesting that this population of cells might have a distinct morphogenetic mode during early embryogenesis (Fig. 3F Right) . Consistent with the ISH results, we also detected coexpression of Brachyury and Foxa2 within the same individual cells within node and DE regions (Fig. 3E, SI Appendix, Fig. S10 B and C, and Movies S2-S4). Brachyury-positive cells express Foxa2 at significantly higher levels than Brachyury-negative cells (Fig. 3G ). This finding is in good agreement with our in vitro results showing that Brachyury directly targets and activates the transcription of Foxa2 and that high and Brachyury low Sox17 high cells are mutually exclusive. Collectively, these results support the model derived from in vitro experiments and suggest that that the regulation of Foxa2 and Sox17 by Brachyury might be regionspecific. Specifically, we note that Sox17 and Foxa2 are also expressed in some embryonic tissues, such as the primitive endoderm, where Brachyury is largely absent (Fig. 3 D and E and Movies S1-S4) (25) . Thus, it is likely that these two genes can be regulated by distinct factors and mechanisms at different developmental stages. It appears that, at least during streak formation, the expression of both genes displays significant reliance on Brachyury (Fig. 3A and SI Appendix, Fig. S9 A and B) .
Probing in Vivo Brachyury Function. To identify Brachyury target genes in vivo and elucidate how Brachyury-mediated regulation contributes to early mouse developmental homeostasis and coordination, we made use of the reported Brachyury mutant Tc (Curtailed) mouse model (26) . Importantly, a single copy of the WT Brachyury transgene rescues the Tc mutant phenotype (27) . Thus, the Tc mouse line should be a useful model for studying Brachyury loss of function. As reported, we found that, by E8.0, Tc/Tc embryos become severely shortened compared with WT embryos (SI Appendix, Fig. S11A ), and by E10.0, Tc/Tc embryos showed dramatic axial and neural fold closure defects (SI Appendix, Fig. S11B ). We next performed mRNA-seq to compare gene-expression profiles of WT and Tc/Tc embryos at both E7.5 ∼8.0 and E10.0 ∼10.5 (SI Appendix, Fig. S11C ). The Brachyury gene becomes highly expressed at E7.5 ∼8.0 (Fig. 4A) , suggesting that these are reasonable stages at which to study the direct impact of Brachyury. Next, we correlated Brachyury target gene information with up-/down-regulated genes in E7.5 ∼8.0 Tc/Tc embryos ( Fig. 4B and Dataset S3). We detected 70 down-regulated and 53 up-regulated functional Brachyury target genes. Thus, it is likely that, although Brachyury targets a large number (1, 942) of genes in the genome, only a small fraction of targeted genes showed gene-activation dependence on Brachyury, consistent with the previous observation that only 81 genes of ∼1,400 targeted genes are dependent of Xbra in Xenopus (12).
Brachyury-Mediated Regulation in Early Development. We next examined whether our integrated genome-wide data are consistent with previous genetic studies and whether our data could link the molecular function of Brachyury to unique developmental and cellular processes. For this analysis, we only considered genes that are directly targeted and up-regulated by Brachyury in vitro and/or in vivo. We also scored each target gene according to its evolutionary conservation (Fig. 4C and Dataset S4). Indeed, consistent with the positive feedback loop between T and Fgf8 (28-30), we found that Fgf8 is under the control of four Brachyurybound enhancer regions (Fig. 1A) and that Fgf8 is down-regulated in both in vitro and in vivo perturbation experiments (Dataset S4). Fgf8 is also a common Brachyury target in mouse and X. tropicalis (Fig. 1F) . In parallel, we found that Brachyury targets the Dusp6 gene, a negative regulator of Fgf signaling (31) (Fig. 1A) . Importantly, this regulatory link between Brachyury and Dusp6 was observed in all three species (Fig. 1F) , suggesting that this pathway is highly conserved. Thus, it is likely that, after first potentiating the Fgf8 signaling, Brachyury also initiates a negative feedback control to ensure the proper attenuation of signaling. Previous genetic studies showed that both Foxa2-null and Brachyury-mutant mice displayed node/notochord defects that manifest between E8 and E10 (27, 32) . Here, we found that Foxa2 is a functional and direct Brachyury target gene (Figs. 1A and 3A and SI Appendix, Fig. S9 A  and B) , suggesting that loss of Foxa2 expression in Brachyurypositive cells might partially explain some of the Brachyury mutant phenotypes. These results are also consistent with the proposed regulation between Brachyury and Foxa2 in organizer derivatives (node/notochord) described by Tamplin et al. (33) . We identified the Mab21l2 gene (SI Appendix, Fig. S8A ), a potential bone morphogenetic protein (BMP) antagonist (34) , as a Brachyury target gene. Although the regulation of Mab21l2 by Brachyury is only found in the mouse, the Mab21l2 gene is downregulated in both in vitro and in vivo Brachyury loss-of-function experiments (Dataset S4). Our results further suggest that Brachyury might coordinate primary cilia formation and leftright axis patterning via regulation of Foxj1, Cdh2, and Tbx6-all of which have been shown to be critical for the establishment of early embryo left-right asymmetry (35) (36) (37) . Consistent with the function of Brachyury in regulating morphogenetic cell movements, Brachyury up-regulates the expression of key epithelialmesenchymal transition (EMT) and cell-mobility regulators (Sox4 and Bves). The functional link between Brachyury and Sox4 also offers mechanistic insights into recent observations that Brachyury promotes the EMT and metastatic behavior of human tumor cells (38) . We also identified other cancer-related genes (Tpd52l1, Ybx1, and Irf1) as direct targets of Brachyury.
Strikingly, we found that Brachyury directly activates a set of hematopoietic regulators (Mixl1, Mllt3, NKX2-3, Sox6, POU4F1, and CD93). Most of these regulatory pathways are not conserved in zebrafish and Xenopus, suggesting that these are evolutionarily divergent networks (Dataset S4). Tc/Tc embryo mRNA-seq results at later stages of development (E10.0∼10.5) confirmed downstream defects in hematopoiesis. Specifically, the fetal hemoglobin genes (Hba-x and Hbb-y) were significantly down-regulated (Fig.  4D) . Importantly, these results agree well with previous observations that hemangioblast commitment is initiated by Brachyurypositive cells in the primitive streak of the mouse embryo (39) and thus further establish a molecular link between Brachyury and hematopoietic lineage specification.
Consistent with the role of Brachyury in directing mesoderm lineages, Brachyury targets and promotes the expression of muscle and chondrocyte regulators (Msgn1, Pax7, My17, Mfhx4, and Sox9). As expected, skeletal muscle development (Myog) was compromised in the E10.0∼10.5 Tc/Tc embryos (Fig. 4D) , consistent with its reported regulatory function in zebrafish (13) .
Methods
Mouse D3 (ATCC) ES cells were used for in vitro differentiation experiments. The T c /J mouse line was obtained from the Jackson Laboratory. Custom-made Brachyury antibodies were used for ChIP-seq/exo experiments. Deep-sequencing was performed with the illumina HiSeq system. Detailed methods are available in SI Appendix, SI Methods. Primer information is available in Dataset S5.
